Search Within

David Hyman

  1. "Graduate Medical Education"
Formats
  1. Meeting Abstract (8)
  2. Journal Article (2)
Groups
  1. Department of Medicine (10)
  2. Early Drug Development Service (10)
  3. GSK Faculty (10)
  4. Graduate Medical Education (10)
  5. Solid Tumor Oncology Division (10)
  6. Department of Pathology and Laboratory Medicine (8)

More Groups

People
  1. Benjamin Durham (5)
  2. Eli Diamond (5)
  3. Estibaliz Lopez Rodrigo (5)
  4. Michael Berger (5)
  5. Omar Abdel-Wahab (5)
  6. David Solit (4)

More People

Years
  1. 2020 (5)
  2. 2019 (3)
  3. 2018 (1)
  4. 2017 (1)
Publications
  1. Blood (1)
  2. Cancer Discovery (1)
  3. Cancer Research (1)
  4. Clinical Cancer Research (1)
  5. Gynecologic Oncology (1)
  6. Journal of Clinical Oncology (1)

More Publications

Publishers
  1. American Association for Cancer Research (3)
  2. Nature Publishing Group (2)
  3. American Society of Clinical Oncology (1)
  4. American Society of Hematology (1)
  5. Elsevier B.V. (1)
  6. Nature Research (1)

More Publishers

Results (10)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The utility of plasma ctDNA for detection of KRAS G12C and other mutations in lung cancers
    Meeting Abstract

    Murciano-Goroff, Y. R.; Arbour, K. C.; Offin, M. D.; Tu, H. Y. Y.; Lebow, E. S.; Shaffer, T. S.; Bertucci, C.; Hosseini, S. A.; Garg, K.; Lim, L. P.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Immune and genomic profiling of small cell carcinomas of the ovary hypercalcemic type
    Meeting Abstract

    Dessources, K.; Holland, A.; Liu, J. D.; Lee, S. S.; Selenica, P.; Wu, M.; Stylianou, A.; Reis-Filho, J.; Hyman, D. M.; Hollmann, T. J.; more...
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • The impact of poly ADP ribose polymerase (PARP) inhibitors on clonal hematopoiesis
    Meeting Abstract

    Bolton, K. L.; Moukarzel, L. A.; Ptashkin, R.; Gao, T.; Patel, M.; Caltabellotta, N.; Braunstein, L. Z.; Aghajanian, C.; Hyman, D. M.; Berger, M. F.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Characterizing KRAS G12C and other mutations in plasma ctDNA from patients with lung cancer
    Meeting Abstract

    Murciano-Goroff, Y. R.; Lebow, E. S.; Tu, H. Y.; Li, M.; Lim, L. P.; Arbour, K. C.; Travis, W.; Solit, D. B.; Ladanyi, M.; Jones, D. R.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Novel alterations in CSF1R, RET, and other diverse kinases in the histiocytoses with biochemical and structural insights into their mechanisms of activation
    Meeting Abstract

    Durham, B.; Lopez-Rodrigo, E.; Picarsic, J.; Abramson, D.; Rotemberg, V.; De Munck, S.; Pannecoucke, E.; Lu, S.; Pastore, A.; Mandelker, D.; more...
    Pediatric Blood and Cancer (2020)

    Fulltext@MSK | Save
  • Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms
    Journal Article

    Durham, B. H.; Lopez Rodrigo, E.; Picarsic, J.; Abramson, D.; Rotemberg, V.; De Munck, S.; Pannecoucke, E.; Lu, S. X.; Pastore, A.; Yoshimi, A.; more...
    Nature Medicine (2019)

    Fulltext@MSK | Save
  • Novel activating mutations in CSF1R and additional kinases with therapeutic implications in histiocytic neoplasms
    Meeting Abstract

    Durham, B.; Picarsic, J.; Lopez-Rodrigo, E.; Hyman, D.; Diamond, E.; Abdel-Wahab, O.
    Modern Pathology (2019)

    Fulltext@MSK | Save
  • Novel activating mutations in CSF1R and additional kinases with therapeutic implications in histiocytic neoplasms
    Meeting Abstract

    Durham, B.; Picarsic, J.; Lopez-Rodrigo, E.; Hyman, D.; Diamond, E.; Abdel-Wahab, O.
    Laboratory Investigation (2019)

    Fulltext@MSK | Save
  • Activating mutations in CSF1R and additional receptor tyrosine kinases in sporadic and familial histiocytic neoplasms
    Meeting Abstract

    Durham, B. H.; Lopez-Rodrigo, E.; Abramson, D. H.; Picarsic, J.; Pastore, A.; Mandelker, D.; Walsh, M. F.; Arcila, M. E.; Ladanyi, M.; Solit, D.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • A next-generation TRK kinase inhibitor overcomes acquired resistance to prior TRK kinase inhibition in patients with TRK fusion-positive solid tumors
    Journal Article

    Drilon, A.; Nagasubramanian, R.; Blake, J. F.; Ku, N.; Tuch, B. B.; Ebata, K.; Smith, S.; Lauriault, V.; Kolakowski, G. R.; Brandhuber, B. J.; more...
    Cancer Discovery (2017)

    Fulltext@MSK | Save